We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
Octopus Group

Download Mobile App

Medlab Middle East 2023 Showcases Latest Laboratory Innovations and Technologies

By LabMedica International staff writers
Posted on 06 Feb 2023
Print article
Image: Medlab Middle East 2023 has seen a 100% increase in exhibitor numbers (Photo courtesy of Informa Markets)
Image: Medlab Middle East 2023 has seen a 100% increase in exhibitor numbers (Photo courtesy of Informa Markets)

The 22nd edition of Medlab Middle East Congress, is taking place live, in-person from 6-9 February 2023, in Dubai with a 100% increase in exhibitor numbers. Co-hosted with Arab Health for the last two years, Medlab Middle East has more than 700 exhibitors displaying the latest laboratory innovations and technologies to an audience of over 20,000 visitors representing more than 180 countries throughout the show's four days.

The 2023 edition of Medlab Middle East, the MENA region’s largest medical laboratory exhibition and congress organized by Informa Markets (London, UK), has returned as a standalone event following unprecedented demand from exhibitors and visitors to attend the show. This year’s exhibition theme ‘paving the way for technological advancements and sustainability in laboratory medicine’ underscores the rate at which laboratory technology has advanced in recent years. In addition to a showcase of products ranging from high-performance solutions and advanced technology to affordable alternatives, Medlab Middle East is revealing a range of new and returning features.

Making its debut at the show is Labpreneur, which gathers the most exciting and promising medical laboratory start-ups from across the world as they actively address the unmet challenges and revolutionize the medical lab industry. The competition features the top 10 innovative early and middle-stage start-ups from across the world, pitching their ground-breaking ideas and battling on stage in front of an esteemed panel of judges, which includes investors, industry experts, and entrepreneurs. Sustainability is also in focus and is being highlighted during the Lab Sustainability Awards. The awards encourage action on various sustainable laboratory areas and link to one of the 17 Sustainable Development Goals (SDGs), part of the 2030 Agenda for Sustainable Development with the winners announced during the last session of the “Sustainability in the lab” conference.

Medlab Middle East is also hosting the LabQ, an inter-college quiz competition focusing on the area of pathology and laboratory medicine for senior graduating college and university students majoring in medical laboratory sciences in the UAE. In addition, the scientific poster competition returning in 2023 is dedicated to helping grow the medical laboratory industry by providing a platform to gain recognition and be published. The winner gets the opportunity to speak at Medlab Asia 2023, which takes place in Bangkok, with flights and accommodation included.

The Medlab Middle East Congress also returns this year, providing education and solutions to advance laboratory skills and improve laboratory functions to over 5,000 conference delegates. With 13 conferences, the Congress is the largest CME-accredited multi-track medical laboratory congress globally, featuring 130+ local and international speakers. This year's conference program includes eight core lab conference tracks​, with a further four new additions addressing Point of Care Testing (POCT), Tech Advances and Clinical Impact, New Trends In Laboratory Medicine, Quality Management in the Lab, and Sustainability in the Lab.

“We have seen the demand for clinical laboratory services increase significantly in the last two years. As such, we’ve witnessed a surge in demand from visitors and exhibitors. COVID-19 undoubtedly put increased focus on the laboratory market. Subsequently, we have seen a wealth of new technology and innovation being adopted, which is driving automation and collaboration with the lab and critical external stakeholders,” said Tom Coleman, Exhibition Director for Inform Markets. “More generally, we have seen factors such as the rising prevalence of chronic illnesses and the resulting need for early diagnostic testing contributing to the growth in the size of the lab market. The speed of technological advances in raising productivity and cost savings will also be a key factor in driving the industry’s growth.”

Related Links:
Informa Markets 

Gold Supplier
Cerebral Spinal Fluid Control
Multichem CSF
Automated Sample Preparation System
BCID Panels
ePlex Blood Culture Identification Panels
Thrombosis Viscoelasic Analysis System

Print article


Clinical Chem.

view channel
Image: Brief schematic diagram of the detection principle and method (Photo courtesy of CAS)

Rapid, Non-Invasive Method Diagnoses Type 2 Diabetes by Sniffing Urinary Acetone

Over 90% of diabetes cases are attributed to Type 2 diabetes (T2D), a prevalent metabolic condition that is expected to impact 380 million individuals globally by 2025. Despite being highly accurate, the... Read more

Molecular Diagnostics

view channel
Image: Researchers have identified the origin of subset of autoantibodies that worsen lupus (Photo courtesy of Pexels)

Lupus Biomarker Testing Could Help Identify Patients That Need Early and Aggressive Treatment

Systemic lupus erythematosus (SLE) is an autoimmune disease that occurs when the body's antibodies, which usually protect against infections, attack healthy cells and proteins. These autoantibodies can... Read more


view channel
Image: A genetic test could guide the use of cancer chemotherapy (Photo courtesy of Pexels)

Genetic Test Predicts Whether Bowel Cancer Patients Can Benefit From Chemotherapy

Late-stage bowel cancer patients usually undergo a series of chemotherapies and targeted medicines for cancer treatment. However, the responses to the last-line chemotherapy treatment trifluridine/tipiracil... Read more


view channel
Image: Use of DBS samples can break barriers in hepatitis C diagnosis and treatment for populations at risk (Photo courtesy of Pexels)

DBS-Based Assay Effective in Hepatitis C Diagnosis and Treatment for At Risk Populations

In a bid to eliminate viral hepatitis as a public health threat by 2030, the World Health Organization (WHO) has put forth a proposed strategy. To this end, researchers at the Germans Trias i Pujol Research... Read more


view channel
Image: New research has opened a path for fast and accurate cancer diagnosis (Photo courtesy of Imagene)

AI-Based Image Analysis Software Profiles Cancer Biomarkers in Real Time

Lung cancer is the most widespread type of cancer worldwide, resulting in approximately 1.76 million fatalities annually. Non-small cell lung cancer (NSCLC) accounts for 85% of all lung cancer diagnoses... Read more


view channel
Image: Live view of non-fluorescent specimens using the glowscope frame (Photo courtesy of Winona State University)

Device Converts Smartphone into Fluorescence Microscope for Just USD 50

Fluorescence microscopes are utilized to examine specimens labeled with fluorescent stains or expressing fluorescent proteins, like those tagged with green fluorescent protein. However, since these microscopes... Read more


view channel
Image: The global antimicrobial resistance diagnostics market size is expected to reach USD 5.7 billion by 2028 (Photo courtesy of Pexels)

Global Antimicrobial Resistance Diagnostics Market Driven by Increasing Hospital-Acquired Infections

Antimicrobial drugs are intended to counteract the harmful effects of microbes and promote a healthy life. However, their excessive use can result in the development of resistance, commonly referred to... Read more
Copyright © 2000-2023 Globetech Media. All rights reserved.